CorEvitas
Waltham · Founded 2000
About CorEvitas
Corrona delivers real-world evidence through syndicated registry data and analytics services to help biopharmaceutical companies demonstrate the value and differentiation of their products to clinicians, patients, payers, and regulators. Corrona operates six autoimmune registries across the USA, Canada, and Japan, collecting data from over 400 participating investigator sites. Corrona's data are unmatched in depth and completeness within clinical measures and patient reported outcomes. Corrona also conducts active safety surveillance to support regulatory commitments for 14 new drug approvals, including formal post authorization safety studies. The company's mission is to advance patient care and improve treatment with real-world data analysis. Corrona was founded on 2000 an d is headquartered in Waltham, Massachusetts.
Company Facts
- Founded: 2000
- Legal name: COREVITAS, LLC
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Estimated revenue: $1K – $10K
- Funding stage: M&A
- Last round: Private Equity (Dec 2019)
- Website: corevitas.com
- Phone: 773-347-1689
Social Profiles
Canonical: https://fsome.com/organization/corevitas-8369380 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.